News and Events

Researchers at the National Biologics Facility (NBF) at The University of Queensland will benefit from a substantial funding boost for COVID-19 research.

Congratulations to our 2020 AIBN Graduates 

Even before being awarded her PhD at the University of Queensland, Yun (Amy) Liu’s research had reached stratospheric heights.

The next critical phase for The University of Queensland’s COVID-19 vaccine, is underway – with the research effort moving out of the lab and into human trials. The vaccine has been developed by Professor Paul Young, Associate Professor Keith Chappell and Dr Dan Watterson who have been driving the program, housed at AIBN, jointly with Project Director, AIBN’s Professor Trent Munro.

A novel rapid cancer diagnostic technology with the potential to quickly and easily detect cancer has been licensed for further development.